Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Ali-Reza Golshayan"'
Autor:
Vadim S. Koshkin, Joaquim Bellmunt, Matthew D. Galsky, Sylvain Ladoire, B.J. Eigl, Bas W.G. van Rhijn, Andrea Necchi, Johnathan E. Rosenberg, Guenter Niegisch, Kees Hendricksen, Salvatore Lo Vullo, Daniel W. Bowles, Sandy Srinivas, Aristotelis Bamias, Ali Reza Golshayan, Evan Y. Yu, Florian Roghmann, Michael Woods, Matthew I. Milowsky, Jakub Dobruch, Petros Grivas, Evanguelos Xylinas, Dominik D. Berthold, Yu-Ning Wong, Neeraj Agarwal, Srikala S. Sridhar, Jack Baniel, Lucia Nappi, Federica Recine, Ulka N. Vaishampayan, Lauren C. Harshman, Ugo De Giorgi, Simon J. Crabb, Luigi Mariani, Carsten Ohlmann, Ajjaj Alva, Sumanta K. Pal, Thomas Powles, Christine Theodore, Cora N. Sternberg
Background: Limited data is available on the role, and extent of, postchemotherapy lymphadenectomy (PC-LND) in patients with clinical evidence of pelvic (cN1-3) or retroperitoneal (RP) lymph node spread from urothelial bladder carcinoma. Objective: T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1307c446564231a2fa47c997161a8a88
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020075093&doi=10.1016/j.euf.2017.05.006&partnerID=40&md5=33648af8ff902fe82347274fdb063143
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020075093&doi=10.1016/j.euf.2017.05.006&partnerID=40&md5=33648af8ff902fe82347274fdb063143
Autor:
Lauren C. Harshman, Ugo De Giorgi, Kevin Chan, Simon J. Crabb, Ulka N. Vaishampayan, Evan Y. Yu, Guru Sonpavde, Günter Niegisch, Cora N. Sternberg, Joaquim Bellmunt, Ali Reza Golshayan, Yu-Ning Wong, Sylvain Ladoire, Rafael Morales-Barrera, Syed A. Hussain, Ajjai Alva, Jonathan E. Rosenberg, Andrea Necchi, Simon Chowdhury, Matthew I. Milowsky, Gregory R. Pond, Daniel W. Bowles, Aristotelis Bamias, Jack Baniel, Matthew D. Galsky, Srikala S. Sridhar, Marc C. Smaldone, Sandy Srinivas, Dominik Berthold, Neeraj Agarwal, Sumanta K. Pal, Thomas Powles, Christine Theodore, Linda Cerbone, Rosalia Viterbo
Publikováno v:
European Urology Focus
European Urology Focus, Elsevier, 2018, 4 (6), pp.937-945. ⟨10.1016/j.euf.2017.03.011⟩
European Urology Focus, Elsevier, 2018, 4 (6), pp.937-945. ⟨10.1016/j.euf.2017.03.011⟩
Background: Little is known about the outcomes of robot-assisted radical cystectomy (RARC) compared to open radical cystectomy (ORC) combined with perioperative chemotherapy for muscle-invasive urothelial bladder cancer (UBC). Objective: To evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc30dcb8081be78c359d6685fc6fd8eb
https://hal.archives-ouvertes.fr/hal-01697161
https://hal.archives-ouvertes.fr/hal-01697161
Autor:
Lorin A. Ferris, Ulka N. Vaishampayan, Jorge Ramos, Aristotelis Bamias, Sumanta K. Pal, Jack Baniel, Olivia A. Do, Evan Y. Yu, Sarah K. Holt, Sandy Srinivas, Lauren C. Harshman, Joaquim Bellmunt, Andrea Necchi, Elizabeth R. Plimack, Ugo De Giorgi, Sylvain Ladoire, Matthew D. Galsky, Simon J. Crabb, Ali Reza Golshayan, Tanya B. Dorff
Publikováno v:
Journal of Clinical Oncology. 38:e17005-e17005
e17005 Background: The optimal choice of first-line chemotherapy for urothelial carcinoma (UC) patients who recur after previous cisplatin-based chemotherapy for locally-advanced disease is unclear. Our objective is to compare the efficacy of platinu
Publikováno v:
Core Evidence
Introduction Enzalutamide is an oral androgen receptor (AR) signaling inhibitor that was specifically engineered to overcome castration-resistant prostate cancer (CRPC) harboring AR amplification or overexpression. Enzalutamide has demonstrated signi
Autor:
Salvatore Lo Vullo, Günter Niegisch, Yu-Ning Wong, Jack Baniel, Sylvain Ladoire, Luigi Mariani, Lauren C. Harshman, Ugo De Giorgi, Daniel W. Bowles, Simon J. Crabb, Sumanta K. Pal, Rafael Morales-Barrera, Guru Sonpavde, Thomas Powles, Andrea Necchi, Christine Theodore, Ajjai Alva, Jonathan E. Rosenberg, Joaquim Bellmunt, Linda Cerbone, Simon Chowdhury, Ulka N. Vaishampayan, Cora N. Sternberg, Evan Y. Yu, Neeraj Agarwal, Aristotelis Bamias, Dominik Berthold, Matthew D. Galsky, Gedske Daugaard, Daniele Giardiello, Ali Reza Golshayan, Matthew I. Milowsky, Sandy Srinivas, Srikala S. Sridhar
Publikováno v:
European Urology
European Urology, Elsevier, 2017, 71 (2), pp.281-289. ⟨10.1016/j.eururo.2016.09.042⟩
European Urology, Elsevier, 2017, 71 (2), pp.281-289. ⟨10.1016/j.eururo.2016.09.042⟩
IF 16.265; International audience; BACKGROUND:The available prognostic models for overall survival (OS) in patients with metastatic urothelial carcinoma (UC) have been derived from clinical trial populations of cisplatin-treated patients.OBJECTIVE:To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30998e7e370c20b414528c5142c9c466
https://europepmc.org/articles/PMC5576985/
https://europepmc.org/articles/PMC5576985/
Autor:
A. Liu, Savannah G. Bandurraga, Laura Spruill, Victoria J. Findlay, Emily Kistner-Griffin, David P. Turner, Ali Reza Golshayan, Ashley Marie Smith
Publikováno v:
Carcinogenesis. 33:572-580
Advanced disease accounts for the majority of prostate cancer-related deaths and androgen deprivation therapy (ADT) is the standard of care for these patients. Many patients undergoing ADT become resistant to its effects and progress to castrate-resi
Autor:
Jonathan C. Picard, Krisha J. Opfermann, David T. Marshall, Ali-Reza Golshayan, Thomas E. Keane
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 30:3-15
Prostate cancer is the most frequently diagnosed cancer and the second most common cause of cancer death in men in the United States. Such men can experience a continuum of disease presentations from indolent to highly aggressive. For physicians who
Autor:
Ali Reza Golshayan, Elizabeth R. Plimack, Jonathan E. Rosenberg, Joaquim Bellmunt, Sylvain Ladoire, Lauren C. Harshman, Aristotle Bamias, Simon J. Crabb, Guenter Niegisch, Sumanta K. Pal, Evan Y. Yu, Thomas Powles, Matthew D. Galsky, Andrea Necchi, Daniel W. Bowles, Srikala S. Sridhar, Dominik Berthold, Greg Pond, Jack Baniel, Neeraj Agarwal
Publikováno v:
Annals of Oncology. 28:v308-v309
Autor:
Peter J. Van Veldhuizen, Maha Hussain, Grant W. Harrer, David Smith, Nicholas J. Vogelzang, Ian M. Thompson, Glenn Mills, Ali Reza Golshayan, Catherine M. Tangen
Publikováno v:
Urology. 77:1172-1176
To assess the efficacy of a multiagent taxane-based chemotherapy combined with hormonal therapy in men with metastatic androgen-dependent prostate cancer in a multicenter, cooperative group, single-arm trial.A total of 41 patients with newly diagnose
Autor:
Laura S. Wood, Jorge A. Garcia, R. Bukowski, G. Khan, Paul Elson, Brian I. Rini, Ali Reza Golshayan
Publikováno v:
Annals of Oncology. 21:1618-1622
Although clinical trials with sunitinib and sorafenib in metastatic renal cell carcinoma (mRCC) have included patients with moderate renal insufficiency (RI), the incidence of renal toxicity induced by their administration as well as the safety of th